logo

For the Inventor, By the Inventor

Tokyo, Japan

Toshiyuki Okutome

This inventor holds 11 USPTO granted patents. Top assignee: Torii & Co., Ltd.. Active years: 1980-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyuki Okutome. Retrieved from https://idiyas.com/inventor/toshiyuki-okutome

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 162(Granted Patents)


Company Filing History:

goldMedal11 out of 26 
 
Torii & Co., Ltd.
 patents

Years Active: 1980-1989

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4820730 - 6-amino-2-naphthyl 4-gusnichinobenzoate derivatives and pharmaceutical (1989-04-11),
2. 4777182 - 6-Amidino-2-naphthyl 4-guanidinobenzoate derivatives and pharmaceutical (1988-10-11),
3. 4634783 - Novel amidine compound (1987-01-06),
4. 4570006 - Amidine compound, process for producing same and anti-complement agent (1986-02-11),
5. 4563527 - Amidine compounds (1986-01-07),
6. 4532255 - Amidine compounds and anticomplement agent comprising same (1985-07-30),
7. 4514416 - Amidine compound, process for producing same and anti-complement agent (1985-04-30),
8. 4496584 - Amidine derivatives with anti-complement activity (1985-01-29),
9. 4490388 - Amidine compound and anticomplement agent comprising same (1984-12-25),
10. 4454338 - Amidine compound (1984-06-12),
11. 4182897 - Amino- or guanidino-phenylpropionic acid derivatives (1980-01-08),

Title: The Innovative Contributions of Toshiyuki Okutome

Introduction

Toshiyuki Okutome is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing novel compounds that have various therapeutic applications.

Latest Patents

Among his latest patents are the 6-amino-2-naphthyl 4-guanidinobenzoate derivatives and pharmaceutical amidine compounds. These compounds are recognized for their potential use as anti-trypsin, anti-plasmin, anti-kallikrein, anti-thrombin, and anti-complement agents, which can be administered orally. The amidine compounds can be synthesized through a reaction between a carboxylic acid compound and 6-amidino-2-naphthol or its acid addition salt.

Career Highlights

Toshiyuki Okutome has established a successful career at Torii & Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research and development efforts have led to advancements in drug formulations and therapeutic agents.

Collaborations

Throughout his career, Okutome has collaborated with notable colleagues, including Toyoo Nakayama and Setsuro Fujii. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Toshiyuki Okutome's contributions to pharmaceutical inventions and his extensive patent portfolio underscore his role as a leading inventor in the industry. His work continues to impact the development of important therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…